EHC - European Haemophilia Consortium / LinkedIn
Dec 16, 2025, 00:32
New on EHCucate: Read about the “History of Replacement Factor Therapies” and More
European Haemophilia Consortium shared a post on LinkedIn:
“From fresh-frozen plasma in the 1950s to today’s extended and ultra-long half-life products—the evolution of replacement factor treatments for bleeding disorders showcases over 70 years of remarkable innovation and ingenuity, culminating in personalised therapy.
Want to dive deeper? Explore these new topics on the EHCucate webpage:
- History of Replacement Factor Therapies (RFT)
- Principles of Factor Replacement
- Practical Foundations of RFT
Learn more”
Follow the latest in Hemostasis Today.
-
Jul 8, 2026, 11:33Ifeanyichukwu Ifechidere: Haemophilia A and B – From First Diagnosis to the Era of Gene Therapy
-
Jul 8, 2026, 10:29Bringing Hemophilia Care Closer to Communities in Togo – WFH
-
Jul 8, 2026, 10:12Natasha Jolakoski: Completing Advanced Training in Thrombosis and Hemostasis
-
Jul 8, 2026, 09:58Rola Ghasoub: Early Intracranial Hemorrhage Remains the Main Barrier to Cure in Acute Promyelocytic Leukemia
-
Jul 8, 2026, 05:53Excellent PhD Defense by Roberta Cirsmaru on Gene Therapy for Hemophilia A – CRH French Reference Center for Hemophilia Lyon
-
Jul 8, 2026, 05:48Riccardo Menandro: How Lipid Nanoparticles Are Shaping the Future of Rare Disease and Hemophilia Treatment
-
Jul 8, 2026, 05:39Daniel Victor Ortigoza: New Evidence from ATLANTIS-4D-CT on Apixaban and Subclinical Valve Thrombosis
-
Jul 8, 2026, 04:50Reza Bavarsad Shahripour: New AHA Guidance on Cryptogenic Stroke with Reduced Left Ventricular Function
-
Jul 7, 2026, 23:20Balaji Balagani: Exploring Pulmonary Embolism